151. CCL2/EGF positive feedback loop between cancer cells and macrophages promotes cell migration and invasion in head and neck squamous cell carcinoma.
- Author
-
Gao L, Wang FQ, Li HM, Yang JG, Ren JG, He KF, Liu B, Zhang W, and Zhao YF
- Subjects
- Carcinoma, Squamous Cell drug therapy, Cell Differentiation, Cell Movement, Cell Polarity, Curcumin pharmacology, Feedback, Physiological, Head and Neck Neoplasms drug therapy, Humans, Monocytes physiology, Neoplasm Invasiveness, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell pathology, Cell Communication, Chemokine CCL2 physiology, Epidermal Growth Factor physiology, Head and Neck Neoplasms pathology, Macrophages physiology
- Abstract
Head and neck squamous cell carcinoma (HNSCC) represents the most frequent malignancy in the head and neck region, and the survival rate has not been improved significantly over the past three decades. It has been reported the infiltrated macrophages contribute to the malignant progression of HNSCC. However, the crosstalk between macrophages and cancer cells remains poorly understood. In the present study, we explored interactions between monocytes/macrophages and HNSCC cells by establishing the direct co-culture system, and found that the crosstalk promoted the migration and invasion of cancer cells by enhancing the invadopodia formation through a CCL2/EGF positive feedback loop. Our results demonstrated HNSCC cells educated monocytes into M2-like macrophages by releasing C-C motif chemokine ligand 2 (CCL2, or MCP-1). And the M2-like macrophages secreted epithelial growth factor (EGF), which increased the motility of HNSCC cells by enhancing the invadopodia formation. These subcellular pseudopodia degraded extracellular matrix (ECM), facilitating tumor local invasion and distant metastasis. Moreover, EGF up-regulated CCL2 expression in HNSCC cells, which recruited monocytes and turned them into M2-like macrophages, thus forming a positive feedback paracrine loop. Finally, we reported that curcumin, a powerful natural drug, suppressed the production of EGF and CCL2 in macrophages and cancer cells, respectively, blocking the feedback loop and suppressing the migration and invasion of HNSCC cells. These results shed light on the possibilities and approaches based on targeting the crosstalk between cancer cells and monocytes/macrophages in HNSCC for potential cancer therapy.
- Published
- 2016
- Full Text
- View/download PDF